Northern Trust’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Northern Trust’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-168,533	Closed	-$445K	–	4355
2020 Q1	$445K	Buy	168,533 +19,385	+13%	+$31.8K	﹤0.01%	3488
2019 Q4	$176K	Sell	149,148 -18,346	-11%	-$29.3K	﹤0.01%	3818
2019 Q3	$287K	Buy	167,494 +1,027	+0.6%	+$3.13K	﹤0.01%	3666
2019 Q2	$789K	Buy	166,467 +12,971	+8%	+$72.6K	﹤0.01%	3434
2019 Q1	$991K	Buy	153,496 +64,818	+73%	+$339K	﹤0.01%	3360
2018 Q4	$446K	Buy	88,678 +36,170	+69%	+$253K	﹤0.01%	3576
2018 Q3	$448K	Buy	52,508 +41,623	+382%	+$461K	﹤0.01%	3663
2018 Q2	$137K	Buy	+10,885	New	+$149K	﹤0.01%	3950

Northern Trust's NTGN Position: Q2 2020 in Review

Northern Trust sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 168,533 shares — an estimated $445K sold.

Northern Trust first reported a position in NTGN in Q2 2018 and held it in 8 quarters. The position peaked at $991K in Q1 2019. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

Northern Trust reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Northern Trust sold 168,533 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $445K.
Northern Trust first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 8 quarters.
Northern Trust's Neon Therapeutics, Inc. Common Stock position peaked at $991K in Q1 2019.
0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Northern Trust's 13F filing for Q2 2020, filed 14 Aug 2020.